These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

435 related items for PubMed ID: 17847934

  • 21. Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotate.
    Teunissen JJ, Kwekkeboom DJ, Krenning EP.
    J Clin Oncol; 2004 Jul 01; 22(13):2724-9. PubMed ID: 15226340
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
    Arnold R, Neuhaus C, Trautmann ME.
    Dtsch Med Wochenschr; 1992 Jul 03; 117(27):1067-71. PubMed ID: 1352235
    [No Abstract] [Full Text] [Related]

  • 25. VIPomas: an update in diagnosis and management in a series of 11 patients.
    Nikou GC, Toubanakis C, Nikolaou P, Giannatou E, Safioleas M, Mallas E, Polyzos A.
    Hepatogastroenterology; 2005 Jul 03; 52(64):1259-65. PubMed ID: 16001675
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide.
    Ricci S, Antonuzzo A, Galli L, Ferdeghini M, Bodei L, Orlandini C, Conte PF.
    Ann Oncol; 2000 Sep 03; 11(9):1127-30. PubMed ID: 11061606
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Presentation, treatment, and outcome of type 1 gastric carcinoid tumors.
    Dakin GF, Warner RR, Pomp A, Salky B, Inabnet WB.
    J Surg Oncol; 2006 Apr 01; 93(5):368-72. PubMed ID: 16550587
    [Abstract] [Full Text] [Related]

  • 30. [The diagnostic value of plasma chromogranin A in neuroendocrine tumors].
    Yang XO, Li JN, Qian JM, Yang H, Chen Q, Lu L.
    Zhonghua Nei Ke Za Zhi; 2011 Feb 01; 50(2):124-7. PubMed ID: 21418832
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Predictive factors of efficacy of the somatostatin analogue octreotide as first line therapy for advanced pancreatic endocrine carcinoma.
    Butturini G, Bettini R, Missiaglia E, Mantovani W, Dalai I, Capelli P, Ferdeghini M, Pederzoli P, Scarpa A, Falconi M.
    Endocr Relat Cancer; 2006 Dec 01; 13(4):1213-21. PubMed ID: 17158766
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Improved survival with higher doses of octreotide long-acting release in gastroenteropancreatic neuroendocrine tumors.
    Lau SC, Abdel-Rahman O, Cheung WY.
    Med Oncol; 2018 Aug 04; 35(9):123. PubMed ID: 30078166
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Chromogranin A: is it a useful marker of neuroendocrine tumors?
    Campana D, Nori F, Piscitelli L, Morselli-Labate AM, Pezzilli R, Corinaldesi R, Tomassetti P.
    J Clin Oncol; 2007 May 20; 25(15):1967-73. PubMed ID: 17513802
    [Abstract] [Full Text] [Related]

  • 38. Comments on "Clinical value of monitoring plasma octreotide levels during chronic octreotide long-acting repeatable therapy in carcinoid patients".
    Schran HF, Hager DF.
    Pancreas; 2008 Oct 20; 37(3):334-5; author reply 336-7. PubMed ID: 18815560
    [No Abstract] [Full Text] [Related]

  • 39. [Treatment of carcinoid syndrome with a somatostatin analogue].
    Döbrönte Z, Stöckert A, Végh G, Varga L.
    Orv Hetil; 1992 Mar 22; 133(12):731-4. PubMed ID: 1372969
    [Abstract] [Full Text] [Related]

  • 40. Parathyroid hormone-related peptide (PTHrP) secretion by gastroenteropancreatic neuroendocrine tumors (GEP-NETs): clinical features, diagnosis, management, and follow-up.
    Kamp K, Feelders RA, van Adrichem RC, de Rijke YB, van Nederveen FH, Kwekkeboom DJ, de Herder WW.
    J Clin Endocrinol Metab; 2014 Sep 22; 99(9):3060-9. PubMed ID: 24905065
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.